Ramer Â· Alavi Nuclear Medicine Technology

More documents

Recommendations

Info

2 Radioactivity, Radiopharmacy, and Quality Assurance 510) A vial of technetium eluate contains 50 mCi/ml. If 4 mlare withdrawn and added to a diphosphonate kitcontaining 16 ml of solution, what volume would thenneed to be withdrawn to prepare a 20 mCi dose at thatmoment?a. 1.0b. 1.5c. 2.0d. 2.511) If a preparation of 99m Tc mertiatide has 60 mCi ofactivity present at 8:30 a.m., how many mCi will bepresent at 9:00 a.m.? (l = 0.944)a. 63.6b. 56.6c. 59.6d. 53.612) Which of the following is boiled during preparation?a. MAAb. sulfur colloidc. albumin colloidd. diphosphonates13) The presence of 12 µg Al 3+ in 1 ml of 99m Tc eluate is:a. an example of radionuclidic impurityb. an example of chemical impurityc. an example of radiochemical impurityd. acceptable since it is less than 15 µg/ml14) Which body decides on the acceptable levels of radionuclidicimpurity?a. USPb. NRCc. FDAd. both a and b
62 Radioactivity, Radiopharmacy, and Quality Assurance15) Which of the following is an example of radionuclidicimpurity?a. presence of free 99m Tc in a preparation of 99m Tc sulfurcolloidb. presence of 99 Mo in 99m Tc eluatec. presence of aluminum ions in 99m Tc eluated. presence of pyrogens in eluate16) What is the maximum amount of aluminum ions (Al 3+ )allowed in one milliliter of 99m Tc eluate according to theUSP?a. none is allowedb. 5 µgc. 10 µgd. 15 µg17) What is indicated by the front of an ITLC strip?a. radionuclidic impurityb. particles of incorrect sizec. pyrogensd. this depends on the solvent and strip used18) If a kit contains 140 mCi of 99m Tc in 23 ml, how muchvolume must be withdrawn to obtain a dose of 5 mCi?a. 0.8 mlb. 30 mlc. 1.2 mld. 0.6 ml19) If a kit contains 140 mCi of 99m Tc in 23 ml at 9:00 a.m.,how much volume must be withdrawn to obtain a doseof 5 mCi at 3:00 p.m.?a. 0.8 mlb. 1.6 mlc. 2.4 mld. 0.6
Page 5 and 6: Table of Contents1 Introduction . .
Page 7 and 8: 21 IntroductionIn response to all o
Page 9: 42 Radioactivity, Radiopharmacy, an
Page 13: 82 Radioactivity, Radiopharmacy, an
Page 17 and 18: 122 Radioactivity, Radiopharmacy, a
Page 25 and 26: 3 Radiation Safety1) Which of the f
Page 27 and 28: 223 Radiation Safety9) Which of the
Page 29 and 30: 243 Radiation Safety18) If the expo
Page 31 and 32: 263 Radiation Safety25) What is the
Page 33 and 34: 283 Radiation Safety33) A technolog
Page 35 and 36: 303 Radiation Safety42) What length
Page 37 and 38: 324 Instrumentation and Quality Ass
Page 53 and 54: 485 Image Presentation and Computer
Page 55 and 56: 505 Image Presentation and Computer
Page 57 and 58: 6 Skeletal System Scintigraphy1) Wh
Page 59 and 60: 546 Skeletal System Scintigraphy10)
Page 61 and 62:
566 Skeletal System Scintigraphy19)
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
7 Central Nervous System Scintigrap
Page 69 and 70:
647 Central Nervous System Scintigr
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
708 Cardiovascular System Scintigra
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
9 Respiratory System Scintigraphy1)
Page 93 and 94:
889 Respiratory System Scintigraphy
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
10 Gastrointestinal Tract Scintigra
Page 103 and 104:
9810 Gastrointestinal Tract Scintig
Page 105 and 106:
10010 Gastrointestinal Tract Scinti
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
11 Genitourinary System Scintigraph
Page 113 and 114:
10811 Genitourinary System Scintigr
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
11812 Neoplasm and Infection Scinti
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
13 Thyroid, Parathyroid,and Salivar
Page 133 and 134:
12813 Thyroid, Parathyroid, and Sal
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
14 Non-Imaging Proceduresand Radion
Page 143 and 144:
13814 Non-Imaging Procedures and Ra
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
15 Patient Care1) Which of the foll
Page 153 and 154:
14815 Patient Care10) Of the follow
Page 155 and 156:
15015 Patient Care18) According to
Page 157 and 158:
16 Mock Examination1) In which radi
Page 159 and 160:
15416 Mock Examination8) A whole bo
Page 161 and 162:
15616 Mock Examination17) The infer
Page 163 and 164:
15816 Mock ExaminationFigure 16.224
Page 165 and 166:
16016 Mock Examination29) Which of
Page 167 and 168:
16216 Mock Examination37) If a pati
Page 169 and 170:
16416 Mock Examination43) A sentine
Page 171 and 172:
16616 Mock Examination53) First pas
Page 173 and 174:
16816 Mock Examination61) What is t
Page 175 and 176:
17016 Mock Examination71) If a SPEC
Page 177 and 178:
17216 Mock Examination79) When inje
Page 179 and 180:
17416 Mock Examination87) To minimi
Page 181 and 182:
Appendix1761.a2.d3.c4.c5.b6.c7.d8.b
Page 183 and 184:
Appendix1781.c2.b3.d4.b5.c6.c7.b8.c
show all

Ramer Â· Alavi Nuclear Medicine Technology

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?